FDA Inspection 1102395 — AnazaoHealth Corporation

AnazaoHealth Corporation — FEI 3011152407

The FDA completed an inspection of AnazaoHealth Corporation on September 19, 2019 in Las Vegas, NV. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 19, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Las Vegas, NV (United States)

Citations

IDCFRDescription
117421 CFR 211.42(b)Product flow through building is inadequate
143521 CFR 211.42(c)(10)(v)Cleaning System